Tag: 上海后花园WM

Go back to the enewsletter For the first time eve

No Comments

first_imgGo back to the e-newsletterFor the first time ever, Huka Lodge has created a new Snow Time Package which takes guests directly to the nearby ski-fields of Turoa and Whakapapa on the slopes of Mt Ruapehu, located in New Zealand’s UNESCO world heritage Tongariro National Park.As the country’s two largest and highest ski areas with over 65 ski trails across 1,050 hectares alone at Whakapapa, all levels of skiers and snowboarders can enjoy world-class amenities and stunning panoramas of volcanic terrain – whether advanced, intermediate or even those just wanting some fun on the slopes. For the truly adventurous, there are over 24 black and double-black diamond runs to ski.With an extended ski season from 2 June to 22 October 2018, the Snow Time Package takes guests straight to the slopes for a day of fun and action before they return to Huka Lodge to luxuriate in its legendary service and some après-ski pampering.The package includes:Accommodation for two nights, for two guests, full country breakfasts, picnic hamper for on the slopes, pre-dinner drinks with canapés and five-course dinners during your stay.After an early breakfast, pick up your picnic hamper and transfer by private vehicle to Tongariro National Park to ski area of your choice.Kit out in your hired jackets, pants, helmet, goggles and gloves and select your ski boots, two poles, skis or snowboard, and pick up a one-day lift pass. 
Take a private lesson with an experienced instructor (for three hours) or simply head to the slopes. 
At the end of the day, relax and rest during your return journey, by private vehicle, to Huka Lodge. 
Gifts of two woollen beanie hats and matching scarves to keep you warm on-piste. 
Huka Lodge, New Zealand and sister properties Dolphin Island, Fiji and Grande Provence Estate, South Africa comprise The Huka Retreats, all sharing a passionate commitment to providing extraordinary hospitality experiences for their guests.Go back to the e-newsletterlast_img read more

NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology

No Comments

first_imgJul 16 2018NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Henry Ford Health System, a non-profit organization, today announce that a newly-formed subsidiary of NTS has entered into multi-year Sponsored Research and License Agreements. The new company is named NeurExo Sciences, LLC (NXS) and its goal is to advance Henry Ford’s pioneering technology involving exosomes as extracellular vesicles enriched with microRNA for the purpose of treating stroke, traumatic brain injury (TBI) including concussion, and neuropathies.Under the Agreements, NXS will license methods and intellectual property (IP) from Henry Ford and fund exosome research projects headed by principal investigator Michael Chopp, Ph.D., Vice Chairman, Department of Neurology, Scientific Director, Neurosciences Institute, at Henry Ford Hospital. NXS will gain worldwide commercial rights to product candidates resulting from the IP and sponsored research coming out of the lab.Related StoriesNew therapy shows promise in preventing brain damage after traumatic brain injurySlug serves as ‘command central’ for determining breast stem cell healthRepurposing a heart drug could increase survival rate of children with ependymomaDr. Chopp and his research team have generated proof-of-principle data in a number of small and large animal models showing how exosomes can amplify the body’s own neurological repair mechanisms and potentially improve long-term neurological outcomes following brain injury, such as stroke or TBI, and neurodegenerative diseases (link to Dr. Chopp’s research here).”Our studies in multiple pre-clinical models indicate that exosomes have the potential to provide significant therapeutic benefits to enhance the recovery from stroke or traumatic brain injury, and potentially with a better safety profile and greater efficacy than their parent or progenitor cells,” said Dr. Chopp. “Success of this novel approach may lead to a shift in the treatment paradigm for TBI, stroke and neurological disease.””We are delighted to collaborate with Dr. Chopp and his research team to advance the next generation of cell-based therapies,” said Carl Long, NeuroTrauma Sciences and NeurExo Sciences Co-founder and Chief Executive Officer. “We believe that exosome technology has the potential to serve as a transformational platform for multiple neurological conditions – including stroke, concussion and other traumatic brain injuries – and NeuroTrauma Sciences is excited to be a part of it.””Henry Ford researchers are pioneers in the exosome field and the NeuroTrauma Sciences team recognized the tremendous potential of our technology and world leading scientists,” said Mark Coticchia, Vice President & Chief Innovation Officer of Henry Ford Health System. “We appreciate their support in pursing the development of this cutting-edge technology with these Agreements, and their commitment to investing in the broader Detroit scientific community with the formation of this new company.” Source:https://www.henryford.com/last_img read more